Clinical Trials for Inozyme Pharma

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Inozyme Pharma

Clinical Trials (4)

NCT06302439
PROPEL - A Prospective Observational Patient Registry to Evaluate ENPP1 and ABCC6 Deficiency
N/ARecruiting
1,000 participants
Started: Jul 25, 2024 · Completed: May 31, 2034
2 conditions2 sponsors13 locations
NCT06462547
ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency
PHASE2Recruiting
200 participants
Started: Jun 19, 2024 · Completed: Dec 31, 2030
5 conditions1 sponsor5 locations
NCT06046820
The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 Deficiency
PHASE3Active, not recruiting
27 participants
Started: Nov 5, 2023 · Completed: Feb 28, 2026
3 conditions1 sponsor15 locations
NCT05734196
The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency
PHASE1Recruiting
16 participants
Started: Jun 25, 2023 · Completed: Apr 1, 2026
5 conditions1 sponsor7 locations